FDA Inspection 592443 — Theravance Biopharma US, Inc.
The FDA completed an inspection of Theravance Biopharma US, Inc. on Jun 25, 2009 in South San Francisco, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 25, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- South San Francisco, CA (United States)
Additional Details
Sponsor, Contract Research Organization